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Abstract
Background: This meta-analysis aimed to evaluate the prognosis and recurrence of apparent early-stage ovarian
tumors treated with laparoscopy compared with laparotomy.
Methods: Clinical studies published in English were retrieved from the computerized databases Medline and Embase. A
meta-analysis was performed to investigate the differences in the efficacy and safety of laparoscopy versus laparotomy in
terms of postoperative complications, lengths of hospital stay, recurrence rates, and disease-free survival times using the
random effects model. The studies were independently reviewed by two investigators. Data from the eligible studies
were extracted, and the meta-analysis was performed using the Comprehensive Meta-Analysis program, version 2
(CMA-2; Biostat, Englewood, NJ, USA).
Results: A total of 8 studies were included in the analysis. The results showed that laparoscopic surgery was significantly
associated with lower rates of complications (OR = 0.433, P = 0.019) and shorter postoperative hospital stays (weighted
mean difference [WMD] = −0.974, P < 0.001). There was no significant difference in the rates of recurrence (OR = 0.707,
P = 0.521) between patients with apparent early-stage ovarian tumors who were treated using laparoscopy and those
who underwent laparotomy. No publication bias was detected.
Conclusions: Laparoscopic surgery shows favorable prognostic outcomes in terms of postoperative complication rates
and postoperative hospital stay durations. Further studies with longer follow-up periods are required to confirm
recurrence and survival outcomes after laparoscopic surgery in patients with apparent early-stage ovarian tumors.
Background
Ovarian cancer is among the major gynecological malig-
nant tumors, and it ranks first in mortality among
gynecological malignancies. Studies have shown that the
5-year survival rate for ovarian cancer is as low as ap-
proximately 30 %, though these rates have markedly in-
creased in recent decades with the development of new
treatments and regimens [1, 2].
Ovarian cancer is difficult to identify in its early
stage, and 70 % of patients are diagnosed at an
advanced stage, resulting in a poor prognosis. Indeed,
the early diagnosis of ovarian cancer is crucial to im-
proving treatment efficacy. Currently, the standard
treatment for early-stage ovarian cancer is primarily
surgical management (with or without chemotherapy).
According to the International Federation of Gynecology
and Obstetrics (FIGO) guidelines, the optimal staging pro-
cedures for ovarian cancer are complete abdominal hys-
terectomy, bilateral salpingo-oophorectomy, peritoneal
biopsy, omentectomy, diaphragmatic scraping, bilateral
pelvic and para-aortic lymph node dissection, and max-
imal debulking efforts to leave “no visible and no palpable
disease” [3]. Clinical practice has proven that laparotomy
is effective as a traditional surgical treatment for ovarian
cancer [4, 5]. In addition, the efficacy of laparoscopy, a
minimally invasive procedure, has been demonstrated in
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recent years [6]. Laparoscopy offers the primary advan-
tages of minimal trauma and rapid recovery and is cur-
rently widely used in the diagnosis and treatment of
malignant gynecological tumors. Studies suggest that
compared with laparotomy, laparoscopy is associated with
shorter hospital stays, lower morbidity, and shorter recov-
ery times [7, 8].
Nonetheless, studies examining the effects of laparos-
copy versus laparotomy in treating apparent early-stage
ovarian cancer have involved limited numbers of pa-
tients, and randomized controlled trials are not available.
The present review systematically combines existing
clinical studies that compared the effects of laparoscopy
versus laparotomy in treating apparent early-stage ovar-
ian cancer to evaluate the prognosis and recurrence of
laparoscopy and reach a conclusion with high credibility.
A random-effects meta-analysis following the MOOSE
guidelines [9] for observational studies and the
QUORUM guidelines for randomized controlled trials
was utilized [10].
Methods
Search strategy for identifying studies
An in-depth literature search was performed using the key-
words “laparoscopy,” “ovarian tumor,” “clinical study,” and
“early-stage” in various combinations. The computerized
databases PubMed (from 1980 to May 2014) and Embase
(from 1980 to May 2014) were searched to identify clinical
studies in English-language journals. We also searched the
related references in the retrieved studies and reviewed arti-
cles from the bibliographic database. The corresponding
authors of some studies were contacted for information be-
yond what was available in their published articles.
Article selection criteria
All clinical studies that explored the differences in prog-
nosis and/or recurrence of apparent early-stage ovarian
tumors (stage I and stage II, according to the FIGO clas-
sification) treated with laparotomy versus laparoscopy
were considered eligible for the analysis. Two investiga-
tors (Ying Zhang and Hua Duan) independently
assessed the articles for relevance. Articles were ex-
cluded if (1) no comparisons were made between laparos-
copy and laparotomy and (2) no standardized effect size
could be calculated. This study was approved by the Insti-
tutional Review Board of the Beijing Obstetrics and
Gynecology Hospital affiliated with the Capital University
of Medical Sciences. All of the procedures used in this
study are in compliance with the Helsinki Declaration.
Statistical analyses
Data management and analysis were performed using
the Comprehensive Meta-Analysis program, version 2
(CMA-2; Biostat, Englewood, NJ, USA). The outcomes
were pooled statistically using the event rates calcu-
lated for postoperative complications and recurrence
rates and the standard mean difference for length of
hospital stay. A random-effects meta-analysis was
conducted to investigate the efficacy and safety of
laparoscopy versus laparotomy to treat apparent early-
stage ovarian tumors.
The measure of heterogeneity was evaluated using
the Cochran Q test. Additionally, heterogeneity (mea-
sured as I2) was used to assess the percentage of the
total variation from all studies. A high value for I2 in-
dicates heterogeneity. Publication bias was evaluated
using Egger’s test.
Results
A total of 387 abstracts were initially selected through
database searches, and 352 articles were excluded be-
cause they failed to meet the inclusion criteria. Of the
remaining 35 articles, 8 did not have a comparison
group, 6 were review articles, 3 focused on different
types of laparoscopic surgery, 2 included the same
data that were presented in other studies, 4 did not
provide sufficient information to calculate an effect
size, and 4 were case studies. The articles excluded
from this study are shown in Fig. 1, and the 8 articles
[8, 11–17] selected for our analysis are shown in
Table 1.
In the 8 studies that were analyzed, the efficacy and
safety of laparoscopy versus laparotomy in the treat-
ment of apparent early-stage ovarian cancer were in-
vestigated. The pooled clinical studies that examined the
prognosis and recurrence of apparent early-stage ovarian
tumors treated with laparoscopy showed that compared
with laparotomy, laparoscopic surgery was significantly as-
sociated with lower complication rates (OR = 0.433, 95 %
CI: 0.215 to 0.869, Z = −2.353, P = 0.019; Fig. 2) and shorter
postoperative hospital stays (WMD= −0.974, SE = 0.220,
Z = −4.420, P < 0.001; Fig. 3). In terms of recurrence rates,
there was no significant difference (OR = 0.707, 95 %
CI: 0.245 to 2.037, Z = −0.642, P = 0.521; Fig. 4) between pa-
tients with apparent early-stage ovarian tumors who were
treated with laparoscopy and those who underwent laparot-
omy. In Liu’s study (2014), the disease-free survival times
were 54.3 months and 57.2 months for patients who were
treated with laparoscopy and laparotomy, respectively.
There was statistically significant heterogeneity in
the models for hospital stay (Q = 24.055, P = 0.001,
I2 = 75.057), but no significant heterogeneity was ob-
served in the models for the rates of complications
(Q = 7.041, P = 0.317, I2 = 14.784) or recurrence (Q = 6.570,
P = 0.255, I2 = 23.898). Publication bias was examined
using funnel plots and Egger’s regression test, and
both indicated that there was no significant publication
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bias (P > 0.05) in the outcomes of this meta-analysis. Con-
sequently, unpublished data were not further evaluated.
Discussion
In gynecologic oncology, laparoscopic surgery is con-
sidered capable of potentially providing a sufficient
degree of visualization, via optical magnification, for
allowing for optimal performance and accurate verifica-
tion of resection, while simultaneously allowing for
preservation of vital structures, such as small vessels,
that may be barely visible to the naked eye [18, 19].
This study aimed to explore the effectiveness of lapar-
oscopy versus laparotomy for the treatment of apparent
early-stage ovarian tumors. The results confirmed the
favorable prognostic outcomes of laparoscopy for redu-
cing the lengths of hospital stays and the rates of post-
operative complications in patients with apparent early-
stage ovarian tumors. Specifically, the aggregated effect
size revealed that laparoscopic surgery was significantly
associated with fewer complications (OR = 0.433, 95 % CI:
0.215 to 0.869, Z = −2.353, P = 0.019) and shorter
postoperative hospital stays (WMD= −0.974, SE = 0.220,
Z = −4.420, P < 0.001). These findings are consistent with
those from studies reporting the advantages of lapar-
oscopy in treating ovarian tumors [7, 12, 20]. Lee
[12] reported that complete surgical staging via lapar-
oscopy (n = 26) resulted in reduced blood loss, earlier
diet resumption, lower postoperative pain scores, and
shorter hospital stays compared with staging via
laparotomy (n = 113) in patients with apparent early-
stage ovarian cancer. Laparoscopic surgery has been
associated with less intraoperative blood loss and
shorter postoperative hospital stays compared with
laparotomy [17, 21]. A major concern regarding lap-
aroscopic surgery is the risk of port-site metastasis,
which has incidence rates of 1 %–16 % [13]. However,
in a number of studies on apparent early-stage ovarian can-
cer, no cases of port-site metastasis or recurrence were re-
ported in patients who had undergone laparoscopy [14, 22].
Additionally, the inability to utilize fine tactile assessment
during laparoscopic surgery to assess the extent of disease
may result in the non-recognition of occult metastatic de-
posits of disease that may be situated within difficult to
visualize areas within the abdomen and pelvis. To compen-
sate for this deficiency in the use of laparoscopic surgery
Fig. 1 Flow chart describing the article selection process
Zhang et al. BMC Cancer  (2015) 15:597 Page 3 of 7

















Laparoscopy Laparotomy Laparoscopy Laparotomy Laparoscopy Laparotomy Laparoscopy Laparotomy Laparoscopy Laparotomy
Liu
2014
50.9 75 NA 20.0 % 209.71 ± 17.57 200.50 ± 20.62 197.14 ± 98.48 345.00 ± 165.95 16.3 ± 6.2 21.9 ± 4.9 18.23 ± 3.27 19.03 ± 3.15 NA NA
Koo
2013
47.6 77 23.5 29.9 % 192.9 ± 73.5 224.1 ± 85.4 697.9 ± 396.9 972.6 ± 827.8 13.7 ± 5.4 13.1 ± 4.1 26.8 ± 8.5 27.8 ± 13.2 17.7 ± 10.1 21.2 ± 11.2
Lee
2011
43.9 113 23.0 26.5 % 227.6 ± 105.8 184.6 ± 61.4 230.4 ± 183.6 474.8 ± 329.2 6.4 ± 2.6 12.4 ± 5.5 23.5 ± 9.3 22.8 ± 10.2 9.9 ± 7.4 4.8 ± 4.1
Park
2008 (1)
44.9 52 22.9 21.2 % 220.7 ± 82.7 274.7 ± 63.2 240.0 ± 228.3 568.2 ± 451.7 8.9 ± 6.1 14.5 ± 5.6 27.2 ± 9.7 33.9 ± 14.5 6.6 ± 6.2 8.8 ± 8.1
Park
2008 (2)
46.2 36 23.5 19.4 % 303.8 ± 84.9 290.4 ± 120.8 231.2 ± 117.9 505.3 ± 279.8 9.4 ± 4.1 14.1 ± 4.2 13.7 ± 5.6 19.3 ± 10.1 8.9 ± 7.1 6.4 ± 3.9
Ghezzi
2007
58.4 34 24.9 29.45 377.0 ± 47.0 272.0 ± 81.0 250.0
(50–1,000)
400 (150–1,000) 3.0 ± 2.5 7.0 ± 2.5 25.2 ± 9.3 25.1 ± 5.8 6.5 ± 3.9 7.0 ± 4.5
Lécuru
2006
49.2 148 NA 19.0 % NA NA NA NA NA NA NA NA NA NA
Chi
2005
49.0 50 25.1 NA 321.0 ± 64.0 276.0 ± 68.0 235.0 ± 138.0 367.0 ± 208.0 3.1 ± 0.7 5.8 ± 2.6 12.3 ± 4.9 14.7 ± 5.7 6.7 ± 2.5 9.2 ± 5.0











for staging, we suggest that preoperative examinations,
such as PET-CTs, be used to detect early metastases so
that they can be resected in a timely manner. Notably,
it is impossible to summarize the hospital stay out-
comes in this meta-analysis because of the studies’ con-
siderable heterogeneity, which could have resulted from
specific differences in the patients’ conditions and the
study designs [20, 23, 24].
In this meta-analysis, no significant difference was de-
tected in the recurrence rates (OR = 0.707, 95 % CI: 0.245
to 2.037, Z = −0.642, P = 0.521) of patients with apparent
early-stage ovarian tumors who were treated laparo-
scopically and those who underwent laparotomy. Koo
[13] conducted a prospective study with a mean follow-
up period of 31 months and found that tumor recur-
rence occurred in 2 (8.3 %) patients in the laparoscopy
group and 2 (3.8 %) in the laparotomy group (P = 0.585).
There was no significant difference in the mean
disease-free survival time, which was excellent in both
groups (59 months after laparoscopy versus 66 months
after laparotomy, P = 0.367). Studies have reported
that laparoscopy decreases surgical morbidity and im-
proves cancer-related survival times by preserving pa-
tients’ cellular immunity [25–27]. In this study, the
pooled disease-free survival time was not computed
because the related data were only available in two of
the included studies (Koo 2013 & Lee 2011). Koo
(2013) reported that laparoscopy and laparotomy were
associated with disease-free survival times of 59.3 ±
3.78 months and 66.3 ± 1.92 months, respectively. In
contrast, Lee (2011) found that patients with appar-
ent early-stage ovarian tumors who received laparos-
copy or laparotomy had disease-free survival times
of 13.3 ± 10.2 months and 25.7 ± 15.0 months, re-
spectively. However, in a large series that included
the laparoscopic staging of 300 patients with appar-
ent early-stage ovarian cancers, laparoscopic surgical
management exhibited excellent safety in terms of
Fig. 2 Forest plot for the aggregated rate of laparoscopy-related complications in patients with apparent early-stage ovarian tumors
Fig. 3 Forest plot for the aggregated length of hospital stays following laparoscopy in patients with apparent early-stage ovarian tumors
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recurrence and death from disease; 25 patients
(8.3 %) underwent immediate laparoscopic staging
and 10 (3.3 %) underwent delayed laparoscopic sta-
ging, and the 3-year disease free survival and overall
survival rates were 85.1 % and 93.6 %, respectively,
for all patients [28]. Future research should include
more studies with relatively longer follow-ups to in-
vestigate recurrence rates and survival outcomes.
The current review retrieved clinical studies pub-
lished through May 2014 that estimated the prognos-
tic outcomes of laparoscopic treatment for apparent
early-stage ovarian tumors. The findings of our review
and meta-analysis are therefore valuable for physicians
and policy makers, given the benefits of laparoscopic
treatment in terms of reducing hospital stays and
complication rates for patients with early-stage ovar-
ian tumors. We employed random-effects models
based on the heterogeneity of the true effects distri-
bution, which avoided the bias of overstating the pre-
cision of findings in fixed-effects models. A limitation
of the current study is the small number of studies
and the limited numbers of participants involved.
This reflects the paucity of high-quality clinical trials
that address the efficacy of laparoscopic surgery for
treating ovarian tumors. Generalizations of this study’s
conclusions to all patients with early-stage ovarian tu-
mors should be considered with caution, and there is
still considerable need for higher quality studies with
relatively larger sample sizes to address this topic.
Conclusion
In conclusion, this meta-analysis confirms that lapar-
oscopy has favorable prognostic outcomes in terms of
the postoperative complications rate and the lengths
of post-operative hospital compared with conventional
laparotomy in the treatment of apparent early-stage
ovarian tumors. Laparoscopic surgery may be effective
and feasible for treating apparent early-stage ovarian
tumors.
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